Clinuvel Pharmaceuticals (CUV.AU) Q1 2026 Earnings

25FebConfirmed
Q3 2024
Q1 2025
Q3 2025
Q1 2026
0.19
0.29
0.39
0.49

Details

Expected EPS
0.27423661965895996
Actual EPS
0.19335010675056885
Surprise EPS
-0.08
Surprise Percent
+29.5%

Description

Clinuvel Pharmaceuticals (CUV.AU) has reported earnings of 0.19335010675056885 per share for Q1 2026.

0 Comments

Share your thoughts